{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:20:21Z","timestamp":1785320421597,"version":"3.55.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00702-018-1863-7","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:48:15Z","timestamp":1519346895000},"page":"995-1005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Antidepressant treatment effects on dopamine transporter availability in patients with major depression: a prospective 123I-FP-CIT SPECT imaging genetic study"],"prefix":"10.1007","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3074-2588","authenticated-orcid":false,"given":"Sabine","family":"Hellwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Frings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Masuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Vach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Normann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp T.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"issue":"2\u20133","key":"1863_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jad.2012.03.007","volume":"141","author":"JD Amsterdam","year":"2012","unstructured":"Amsterdam JD, Newberg AB, Soeller I, Shults J (2012) Greater striatal dopamine transporter density may be associated with major depressive episode. J Affect Disord 141(2\u20133):425\u2013431. \n                    https:\/\/doi.org\/10.1016\/j.jad.2012.03.007","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"1863_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2005.08.016","volume":"89","author":"M Argyelan","year":"2005","unstructured":"Argyelan M, Szabo Z, Kanyo B, Tanacs A, Kovacs Z, Janka Z, Pavics L (2005) Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord 89(1\u20133):115\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.jad.2005.08.016","journal-title":"J Affect Disord"},{"issue":"2","key":"1863_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/YCT.0000000000000138","volume":"30","author":"P Baldinger","year":"2014","unstructured":"Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R (2014) Neurotransmitters and electroconvulsive therapy. J ECT 30(2):116\u2013121. \n                    https:\/\/doi.org\/10.1097\/YCT.0000000000000138","journal-title":"J ECT"},{"issue":"Suppl 2","key":"1863_CR4","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1007\/s00406-010-0152-8","volume":"260","author":"L Bartova","year":"2010","unstructured":"Bartova L, Berger A, Pezawas L (2010) Is there a personalized medicine for mood disorders? Eur Arch Psychiatry Clin Neurosci 260(Suppl 2):S121\u2013S126. \n                    https:\/\/doi.org\/10.1007\/s00406-010-0152-8","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"1863_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0165-1781(03)00096-9","volume":"118","author":"F Benedetti","year":"2003","unstructured":"Benedetti F, Serretti A, Colombo C, Lilli R, Lorenzi C, Smeraldi E (2003) Dopamine receptor D2 and D3 gene variants are not associated with the antidepressant effect of total sleep deprivation in bipolar depression. Psychiatry Res 118(3):241\u2013247","journal-title":"Psychiatry Res"},{"issue":"10","key":"1863_CR6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1176\/appi.ajp.160.10.1836","volume":"160","author":"DJ Brunswick","year":"2003","unstructured":"Brunswick DJ, Amsterdam JD, Mozley PD, Newberg A (2003) Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging. Am J Psychiatry 160(10):1836\u20131841. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.160.10.1836","journal-title":"Am J Psychiatry"},{"issue":"4","key":"1863_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00406-014-0573-x","volume":"265","author":"E Bubl","year":"2015","unstructured":"Bubl E, Kern E, Ebert D, Riedel A, Tebartz van Elst L, Bach M (2015) Retinal dysfunction of contrast processing in major depression also apparent in cortical activity. Eur Arch Psychiatry Clin Neurosci 265(4):343\u2013350. \n                    https:\/\/doi.org\/10.1007\/s00406-014-0573-x","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"1863_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/YCT.0b013e31821646b6","volume":"27","author":"E Bui","year":"2011","unstructured":"Bui E, Delrieu J, Wagner T, Rieu J, Very E, Letamendia C, Payoux P, Schmitt L (2011) Iodine-123 fluoropropyl-carbomethoxy-3-beta-(4-iodophenyltropane) single-photon emission computed tomography findings before and after electroconvulsive therapy in major depressive disorder with Parkinsonism. J ECT 27(4):331\u2013333. \n                    https:\/\/doi.org\/10.1097\/YCT.0b013e31821646b6","journal-title":"J ECT"},{"key":"1863_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpsychires.2013.12.006","volume":"51","author":"G Camardese","year":"2014","unstructured":"Camardese G, Di Giuda D, Di Nicola M, Cocciolillo F, Giordano A, Janiri L, Guglielmo R (2014) Imaging studies on dopamine transporter and depression: a review of literature and suggestions for future research. J Psychiatr Res 51:7\u201318. \n                    https:\/\/doi.org\/10.1016\/j.jpsychires.2013.12.006","journal-title":"J Psychiatr Res"},{"issue":"1","key":"1863_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.euroneuro.2004.06.004","volume":"15","author":"KA Cheon","year":"2005","unstructured":"Cheon KA, Ryu YH, Kim JW, Cho DY (2005) The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate. Eur Neuropsychopharmacol 15(1):95\u2013101. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2004.06.004","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5 Suppl","key":"1863_CR11","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1016\/S0893-133X(01)00324-4","volume":"25","author":"CP Clark","year":"2001","unstructured":"Clark CP, Frank LR, Brown GG (2001) Sleep deprivation, EEG, and functional MRI in depression: preliminary results. Neuropsychopharmacology 25(5 Suppl):S79\u2013S84. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(01)00324-4","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"1863_CR12","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/syn.20927","volume":"65","author":"A Costa","year":"2011","unstructured":"Costa A, Riedel M, Muller U, Moller HJ, Ettinger U (2011) Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies. Synapse 65(10):998\u20131005. \n                    https:\/\/doi.org\/10.1002\/syn.20927","journal-title":"Synapse"},{"issue":"4","key":"1863_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1176\/appi.ajp.2013.13030325","volume":"171","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW (2014) Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry 171(4):453\u2013462. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.2013.13030325","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1863_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tins.2011.11.005","volume":"35","author":"A Der-Avakian","year":"2012","unstructured":"Der-Avakian A, Markou A (2012) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35(1):68\u201377. \n                    https:\/\/doi.org\/10.1016\/j.tins.2011.11.005","journal-title":"Trends Neurosci"},{"issue":"12","key":"1863_CR15","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00259-012-2232-7","volume":"39","author":"D Giuda Di","year":"2012","unstructured":"Di Giuda D, Camardese G, Bentivoglio AR, Cocciolillo F, Guidubaldi A, Pucci L, Bruno I, Janiri L, Giordano A, Fasano A (2012) Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging 39(12):1937\u20131948. \n                    https:\/\/doi.org\/10.1007\/s00259-012-2232-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1863_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.12740\/PP\/30455","volume":"49","author":"E Dopierala","year":"2015","unstructured":"Dopierala E, Rybakowski J (2015) Sleep deprivation as a method of chronotherapy in the treatment of depression. Psychiatr Pol 49(3):423\u2013433. \n                    https:\/\/doi.org\/10.12740\/PP\/30455","journal-title":"Psychiatr Pol"},{"issue":"1","key":"1863_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002130050732","volume":"140","author":"D Ebert","year":"1998","unstructured":"Ebert D, Berger M (1998) Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology 140(1):1\u201310","journal-title":"Psychopharmacology"},{"issue":"11","key":"1863_CR18","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/0006-3223(94)90024-8","volume":"35","author":"D Ebert","year":"1994","unstructured":"Ebert D, Feistel H, Kaschka W, Barocka A, Pirner A (1994) Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation\u2014preliminary results. Biol Psychiatry 35(11):880\u2013885","journal-title":"Biol Psychiatry"},{"issue":"4","key":"1863_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/0893-133X(95)00237-8","volume":"15","author":"D Ebert","year":"1996","unstructured":"Ebert D, Albert R, Hammon G, Strasser B, May A, Merz A (1996) Eye-blink rates and depression. Is the antidepressant effect of sleep deprivation mediated by the dopamine system? Neuropsychopharmacology 15(4):332\u2013339. \n                    https:\/\/doi.org\/10.1016\/0893-133X(95)00237-8","journal-title":"Neuropsychopharmacology"},{"issue":"8\u20139","key":"1863_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s007020070048","volume":"107","author":"PA Fall","year":"2000","unstructured":"Fall PA, Ekberg S, Granerus AK, Granerus G (2000) ECT in Parkinson\u2019s disease-dopamine transporter visualised by [123I]-beta-CIT SPECT. J Neural Transm 107(8\u20139):997\u20131008. \n                    https:\/\/doi.org\/10.1007\/s007020070048","journal-title":"J Neural Transm"},{"issue":"2","key":"1863_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/brb3.20","volume":"1","author":"A Felten","year":"2011","unstructured":"Felten A, Montag C, Markett S, Walter NT, Reuter M (2011) Genetically determined dopamine availability predicts disposition for depression. Brain Behav 1(2):109\u2013118. \n                    https:\/\/doi.org\/10.1002\/brb3.20","journal-title":"Brain Behav"},{"issue":"4","key":"1863_CR22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00702-011-0615-8","volume":"118","author":"P Fernandez-Corcuera","year":"2011","unstructured":"Fernandez-Corcuera P, Aguilar S, Vicens V, Mora J, Benitez A, Garcia-Burillo A, Pomarol-Clotet E, McKenna P (2011) ECT in a patient with Parkinson\u2019s disease and schizophrenia, with dopamine transporter visualisation using 123I-ioflupane SPET. J Neural Transm 118(4):647\u2013650. \n                    https:\/\/doi.org\/10.1007\/s00702-011-0615-8","journal-title":"J Neural Transm"},{"key":"1863_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fpsyt.2013.00094","volume":"4","author":"R Fosse","year":"2013","unstructured":"Fosse R, Read J (2013) Electroconvulsive treatment: hypotheses about mechanisms of action. Front Psychiatry 4:94. \n                    https:\/\/doi.org\/10.3389\/fpsyt.2013.00094","journal-title":"Front Psychiatry"},{"issue":"2","key":"1863_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/sj.tpj.6500026","volume":"1","author":"S Fuke","year":"2001","unstructured":"Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics 1(2):152\u2013156","journal-title":"Pharmacogenomics"},{"issue":"8","key":"1863_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn.2016.57","volume":"17","author":"AA Grace","year":"2016","unstructured":"Grace AA (2016) Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci 17(8):524\u2013532. \n                    https:\/\/doi.org\/10.1038\/nrn.2016.57","journal-title":"Nat Rev Neurosci"},{"key":"1863_CR26","doi-asserted-by":"publisher","DOI":"10.1177\/1747493016632257","author":"V Guiraud","year":"2016","unstructured":"Guiraud V, Gallarda T, Calvet D, Turc G, Oppenheim C, Rouillon F, Mas JL (2016) Depression predictors within six months of ischemic stroke: the DEPRESS Study. Int J Stroke. \n                    https:\/\/doi.org\/10.1177\/1747493016632257","journal-title":"Int J Stroke"},{"key":"1863_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1863_CR28","volume-title":"BDI-II. Beck Depressions Inventar Revision\u2014Manual","author":"M Hautzinger","year":"2006","unstructured":"Hautzinger M, Keller F, K\u00fchner C (2006) BDI-II. Beck Depressions Inventar Revision\u2014Manual. Harcourt Test Services, Frankfurt"},{"issue":"5","key":"1863_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","volume":"30","author":"WT Heijnen","year":"2010","unstructured":"Heijnen WT, Birkenhager TK, Wierdsma AI, van den Broek WW (2010) Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol 30(5):616\u2013619. \n                    https:\/\/doi.org\/10.1097\/JCP.0b013e3181ee0f5f","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"1863_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0893-133X(99)00099-8","volume":"22","author":"A Heinz","year":"2000","unstructured":"Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, Lee KS, Linnoila M, Weinberger DR (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22(2):133\u2013139. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(99)00099-8","journal-title":"Neuropsychopharmacology"},{"key":"1863_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jad.2014.12.043","volume":"175","author":"I Helmreich","year":"2015","unstructured":"Helmreich I, Wagner S, Konig J, Kohnen R, Szegedi A, Hiemke C, Tadic A (2015) Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment. J Affect Disord 175:199\u2013208. \n                    https:\/\/doi.org\/10.1016\/j.jad.2014.12.043","journal-title":"J Affect Disord"},{"issue":"7","key":"1863_CR32","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1586\/ern.10.83","volume":"10","author":"UM Hemmeter","year":"2010","unstructured":"Hemmeter UM, Hemmeter-Spernal J, Krieg JC (2010) Sleep deprivation in depression. Expert Rev Neurother 10(7):1101\u20131115. \n                    https:\/\/doi.org\/10.1586\/ern.10.83","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"1863_CR33","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1523\/JNEUROSCI.4128-13.2014","volume":"34","author":"SC Holst","year":"2014","unstructured":"Holst SC, Bersagliere A, Bachmann V, Berger W, Achermann P, Landolt HP (2014) Dopaminergic role in regulating neurophysiological markers of sleep homeostasis in humans. J Neurosci 34(2):566\u2013573. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4128-13.2014","journal-title":"J Neurosci"},{"issue":"3","key":"1863_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.pscychresns.2010.09.004","volume":"184","author":"PC Hsieh","year":"2010","unstructured":"Hsieh PC, Lee IH, Yeh TL, Chen KC, Huang HC, Chen PS, Yang YK, Yao WJ, Lu RB, Chiu NT (2010) Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression\u2014a dual-isotope SPECT study. Psychiatry Res 184(3):157\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.pscychresns.2010.09.004","journal-title":"Psychiatry Res"},{"issue":"9","key":"1863_CR35","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27(9):1533\u20131539. \n                    https:\/\/doi.org\/10.1038\/sj.jcbfm.9600493","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"1863_CR36","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1176\/appi.ajp.157.10.1700","volume":"157","author":"LK Jacobsen","year":"2000","unstructured":"Jacobsen LK, Staley JK, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, Gelernter J (2000) Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 157(10):1700\u20131703. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.157.10.1700","journal-title":"Am J Psychiatry"},{"issue":"6","key":"1863_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):617\u2013627. \n                    https:\/\/doi.org\/10.1001\/archpsyc.62.6.617","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"1863_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/YCT.0b013e318157ac58","volume":"24","author":"N Khalid","year":"2008","unstructured":"Khalid N, Atkins M, Tredget J, Giles M, Champney-Smith K, Kirov G (2008) The effectiveness of electroconvulsive therapy in treatment-resistant depression: a naturalistic study. J ECT 24(2):141\u2013145. \n                    https:\/\/doi.org\/10.1097\/YCT.0b013e318157ac58","journal-title":"J ECT"},{"issue":"1","key":"1863_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/sj.tpj.6500398","volume":"7","author":"J Kirchheiner","year":"2007","unstructured":"Kirchheiner J, Nickchen K, Sasse J, Bauer M, Roots I, Brockmoller J (2007) A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment. Pharmacogenomics 7(1):48\u201355. \n                    https:\/\/doi.org\/10.1038\/sj.tpj.6500398","journal-title":"Pharmacogenomics"},{"issue":"3","key":"1863_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s002130051005","volume":"144","author":"T Laasonen-Balk","year":"1999","unstructured":"Laasonen-Balk T, Kuikka J, Viinamaki H, Husso-Saastamoinen M, Lehtonen J, Tiihonen J (1999) Striatal dopamine transporter density in major depression. Psychopharmacology 144(3):282\u2013285","journal-title":"Psychopharmacology"},{"issue":"3","key":"1863_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00406-004-0458-5","volume":"254","author":"T Laasonen-Balk","year":"2004","unstructured":"Laasonen-Balk T, Viinamaki H, Kuikka JT, Husso-Saastamoinen M, Lehtonen J, Tiihonen J (2004) 123I-beta-CIT binding and recovery from depression. A six-month follow-up study. Eur Arch Psychiatry Clin Neurosci 254(3):152\u2013155. \n                    https:\/\/doi.org\/10.1007\/s00406-004-0458-5","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"1863_CR42","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/npp.2010.182","volume":"36","author":"AM Landau","year":"2011","unstructured":"Landau AM, Chakravarty MM, Clark CM, Zis AP, Doudet DJ (2011) Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates. Neuropsychopharmacology 36(2):511\u2013518. \n                    https:\/\/doi.org\/10.1038\/npp.2010.182","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"1863_CR43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.neulet.2008.06.042","volume":"441","author":"SM Lehto","year":"2008","unstructured":"Lehto SM, Tolmunen T, Kuikka J, Valkonen-Korhonen M, Joensuu M, Saarinen PI, Vanninen R, Ahola P, Tiihonen J, Lehtonen J (2008) Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study. Neurosci Lett 441(3):291\u2013295. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2008.06.042","journal-title":"Neurosci Lett"},{"key":"1863_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/nyas.12759","volume":"1344","author":"MS Lener","year":"2015","unstructured":"Lener MS, Iosifescu DV (2015) In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature. Ann N Y Acad Sci 1344:50\u201365. \n                    https:\/\/doi.org\/10.1111\/nyas.12759","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"1863_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/sleep\/33.2.243","volume":"33","author":"RC Martins","year":"2010","unstructured":"Martins RC, Andersen ML, Garbuio SA, Bittencourt LR, Guindalini C, Shih MC, Hoexter MQ, Bressan RA, Castiglioni ML, Tufik S (2010) Dopamine transporter regulation during four nights of REM sleep deprivation followed by recovery\u2014an in vivo molecular imaging study in humans. Sleep 33(2):243\u2013251","journal-title":"Sleep"},{"issue":"4","key":"1863_CR46","first-page":"235","volume":"27","author":"R McIntyre","year":"2002","unstructured":"McIntyre R, Kennedy S, Bagby RM, Bakish D (2002) Assessing full remission. J Psychiatry Neurosci 27(4):235\u2013239","journal-title":"J Psychiatry Neurosci"},{"issue":"8","key":"1863_CR47","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/ajmg.b.10948","volume":"114","author":"J Mill","year":"2002","unstructured":"Mill J, Asherson P, Browes C, D\u2019Souza U, Craig I (2002) Expression of the dopamine transporter gene is regulated by the 3\u2032 UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114(8):975\u2013979. \n                    https:\/\/doi.org\/10.1002\/ajmg.b.10948","journal-title":"Am J Med Genet"},{"issue":"Suppl 1","key":"1863_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2165\/1159616-S0-000000000-00000","volume":"31","author":"R Moreira","year":"2011","unstructured":"Moreira R (2011) The efficacy and tolerability of bupropion in the treatment of major depressive disorder. Clin Drug Investig 31(Suppl 1):5\u201317. \n                    https:\/\/doi.org\/10.2165\/1159616-S0-000000000-00000","journal-title":"Clin Drug Investig"},{"issue":"9590","key":"1863_CR49","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","volume":"370","author":"S Moussavi","year":"2007","unstructured":"Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370(9590):851\u2013858. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(07)61415-9","journal-title":"Lancet"},{"issue":"8","key":"1863_CR50","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1017\/S003329170105434z","volume":"31","author":"A Neumeister","year":"2001","unstructured":"Neumeister A, Willeit M, Praschak-Rieder N, Asenbaum S, Stastny J, Hilger E, Pirker W, Konstantinidis A, Kasper S (2001) Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychol Med 31(8):1467\u20131473","journal-title":"Psychol Med"},{"issue":"2","key":"1863_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.pneurobio.2010.06.003","volume":"92","author":"EM Opmeer","year":"2010","unstructured":"Opmeer EM, Kortekaas R, Aleman A (2010) Depression and the role of genes involved in dopamine metabolism and signalling. Prog Neurobiol 92(2):112\u2013133. \n                    https:\/\/doi.org\/10.1016\/j.pneurobio.2010.06.003","journal-title":"Prog Neurobiol"},{"issue":"5","key":"1863_CR52","doi-asserted-by":"publisher","first-page":"e93772","DOI":"10.1371\/journal.pone.0093772","volume":"9","author":"KM Pearson-Fuhrhop","year":"2014","unstructured":"Pearson-Fuhrhop KM, Dunn EC, Mortero S, Devan WJ, Falcone GJ, Lee P, Holmes AJ, Hollinshead MO, Roffman JL, Smoller JW, Rosand J, Cramer SC (2014) Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression. PLoS One 9(5):e93772. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0093772","journal-title":"PLoS One"},{"issue":"1","key":"1863_CR53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.tics.2011.12.011","volume":"16","author":"JL Price","year":"2012","unstructured":"Price JL, Drevets WC (2012) Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn Sci 16(1):61\u201371. \n                    https:\/\/doi.org\/10.1016\/j.tics.2011.12.011","journal-title":"Trends Cogn Sci"},{"issue":"6","key":"1863_CR54","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.euroneuro.2014.12.010","volume":"25","author":"A Rominger","year":"2015","unstructured":"Rominger A, Cumming P, Brendel M, Xiong G, Zach C, Karch S, Tatsch K, Bartenstein P, la Fougere C, Koch W, Pogarell O (2015) Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: a [123I]beta-CIT SPECT study. Eur Neuropsychopharmacol 25(6):873\u2013881. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2014.12.010","journal-title":"Eur Neuropsychopharmacol"},{"issue":"14","key":"1863_CR55","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/mds.22702","volume":"24","author":"F Roselli","year":"2009","unstructured":"Roselli F, Pisciotta NM, Perneczky R, Pennelli M, Aniello MS, De Caro MF, Ferrannini E, Tartaglione B, Defazio G, Rubini G, Livrea P (2009) Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Mov Disord 24(14):2097\u20132103. \n                    https:\/\/doi.org\/10.1002\/mds.22702","journal-title":"Mov Disord"},{"issue":"6","key":"1863_CR56","doi-asserted-by":"publisher","first-page":"793","DOI":"10.4088\/JCP.08m04746blu","volume":"71","author":"T Saijo","year":"2010","unstructured":"Saijo T, Takano A, Suhara T, Arakawa R, Okumura M, Ichimiya T, Ito H, Okubo Y (2010) Electroconvulsive therapy decreases dopamine D(2)receptor binding in the anterior cingulate in patients with depression: a controlled study using positron emission tomography with radioligand [(1)(1)C]FLB 457. J Clin Psychiatry 71(6):793\u2013799. \n                    https:\/\/doi.org\/10.4088\/JCP.08m04746blu","journal-title":"J Clin Psychiatry"},{"issue":"2\u20133","key":"1863_CR57","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pscychresns.2006.03.001","volume":"147","author":"M Sarchiapone","year":"2006","unstructured":"Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S (2006) Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res 147(2\u20133):243\u2013248. \n                    https:\/\/doi.org\/10.1016\/j.pscychresns.2006.03.001","journal-title":"Psychiatry Res"},{"issue":"2","key":"1863_CR58","doi-asserted-by":"publisher","first-page":"246","DOI":"10.4088\/JCP.v69n0211","volume":"69","author":"MH Trivedi","year":"2008","unstructured":"Trivedi MH, Hollander E, Nutt D, Blier P (2008) Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry 69(2):246\u2013258","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"1863_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2967\/jnumed.108.053652","volume":"50","author":"E Giessen van de","year":"2009","unstructured":"van de Giessen E, de Win MM, Tanck MW, van den Brink W, Baas F, Booij J (2009) Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50(1):45\u201352. \n                    https:\/\/doi.org\/10.2967\/jnumed.108.053652","journal-title":"J Nucl Med"},{"issue":"5","key":"1863_CR60","first-page":"745","volume":"46","author":"CH Dyck van","year":"2005","unstructured":"van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, Baldwin RM, Innis RB, Gelernter J (2005) Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46(5):745\u2013751","journal-title":"J Nucl Med"},{"issue":"34","key":"1863_CR61","doi-asserted-by":"publisher","first-page":"8454","DOI":"10.1523\/JNEUROSCI.1443-08.2008","volume":"28","author":"ND Volkow","year":"2008","unstructured":"Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Wong C, Ma J, Pradhan K, Tomasi D, Thanos PK, Ferre S, Jayne M (2008) Sleep deprivation decreases binding of [11C]raclopride to dopamine D2\/D3 receptors in the human brain. J Neurosci 28(34):8454\u20138461. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1443-08.2008","journal-title":"J Neurosci"},{"issue":"19","key":"1863_CR62","doi-asserted-by":"publisher","first-page":"6711","DOI":"10.1523\/JNEUROSCI.0045-12.2012","volume":"32","author":"ND Volkow","year":"2012","unstructured":"Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Logan J, Benveniste H, Kim R, Thanos PK, Ferre S (2012) Evidence that sleep deprivation downregulates dopamine D2R in ventral striatum in the human brain. J Neurosci 32(19):6711\u20136717. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.0045-12.2012","journal-title":"J Neurosci"},{"issue":"2","key":"1863_CR63","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2012-304811","volume":"85","author":"C Vriend","year":"2014","unstructured":"Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, Smit JH, Berendse HW, van den Heuvel OA (2014) Depressive symptoms in Parkinson\u2019s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85(2):159\u2013164. \n                    https:\/\/doi.org\/10.1136\/jnnp-2012-304811","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1863_CR64","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/RLU.0b013e318251e1b3","volume":"37","author":"OH Winz","year":"2012","unstructured":"Winz OH, Hellwig S, Mix M, Weber WA, Mottaghy FM, Schafer WM, Meyer PT (2012) Image quality and data quantification in dopamine transporter SPECT: advantage of 3-dimensional OSEM reconstruction? Clin Nucl Med 37(9):866\u2013871. \n                    https:\/\/doi.org\/10.1097\/RLU.0b013e318251e1b3","journal-title":"Clin Nucl Med"},{"issue":"5 Suppl","key":"1863_CR65","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.1016\/S0893-133X(01)00336-0","volume":"25","author":"JC Wu","year":"2001","unstructured":"Wu JC, Buchsbaum M, Bunney WE Jr (2001) Clinical neurochemical implications of sleep deprivation\u2019s effects on the anterior cingulate of depressed responders. Neuropsychopharmacology 25(5 Suppl):S74\u2013S78. \n                    https:\/\/doi.org\/10.1016\/S0893-133X(01)00336-0","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1863_CR66","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1176\/appi.neuropsych.23.1.63","volume":"23","author":"H Wu","year":"2011","unstructured":"Wu H, Lou C, Huang Z, Shi G (2011) SPECT imaging of dopamine transporters with (99m)Tc-TRODAT-1 in major depression and Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 23(1):63\u201367. \n                    https:\/\/doi.org\/10.1176\/appi.neuropsych.23.1.6310.1176\/jnp.23.1.jnp63","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"1863_CR67","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pscychresns.2007.08.008","volume":"162","author":"YK Yang","year":"2008","unstructured":"Yang YK, Yeh TL, Yao WJ, Lee IH, Chen PS, Chiu NT, Lu RB (2008) Greater availability of dopamine transporters in patients with major depression\u2014a dual-isotope SPECT study. Psychiatry Res 162(3):230\u2013235. \n                    https:\/\/doi.org\/10.1016\/j.pscychresns.2007.08.008","journal-title":"Psychiatry Res"},{"issue":"1","key":"1863_CR68","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0163-7258(01)00158-9","volume":"92","author":"NR Zahniser","year":"2001","unstructured":"Zahniser NR, Doolen S (2001) Chronic and acute regulation of Na+\/Cl\u2212-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92(1):21\u201355","journal-title":"Pharmacol Ther"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-018-1863-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1863-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-018-1863-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T19:57:25Z","timestamp":1550865445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-018-1863-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1863"],"URL":"https:\/\/doi.org\/10.1007\/s00702-018-1863-7","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SH received research support from GE Healthcare Buchler GmbH & Co. KG. WV received funding for travel and speaker honoria from Deutsche Krankenhausgesellschaft and serves as a consultant for the Nordic Institute for Chiropractice and Clinical Biomechanics, Odense, Denmark, and Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark. PTM, ongoing research support from GE Healthcare, Novartis, Piramal Imaging; LF, AM, CN, and KD report no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}